Premier Alternatives

Remedy Plan Therapeutics

Gaithersburg, MD · Founded 2012 · Privately Held (backing)

Developer of medical drugs designed to halt tumor growth and prevent cancer. Remedy Plan Therapeutics is based in Gaithersburg, MD and was founded in 2012. Its last reported valuation was $55 million in Aug 2023. It has raised $47.6 million.

Last reported valuation
$55.0M
Oct 2026
Priced at
—
Total raised
$47.6M
Last round
—

Remedy Plan Therapeutics key facts

as of Oct 2026
  • Developer of medical drugs designed to halt tumor growth and prevent cancer.
  • Remedy Plan Therapeutics is valued at approximately $55.0M as of Oct 2026 (last reported valuation).
  • It has raised $47.6M; the latest was Later Stage VC ($18.0M) in May 2025.
  • Notable investors include Alexandria Venture Investments, Schooner Capital, 20/20 HealthCare Partners, Maryland Tech Council, QB3.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$55.0M

Remedy Plan Therapeutics's last reported valuation, Aug 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Private Market View
More of Remedy Plan Therapeutics with a free Private Market View account
  • ·Watch Remedy Plan Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Remedy Plan Therapeutics funding rounds

No rounds on record

No funding rounds for Remedy Plan Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Remedy Plan Therapeutics valuation

Remedy Plan Therapeutics's last reported valuation was $55 million in Aug 2023. No priced round, secondary trade or fund mark has surfaced since.

Remedy Plan Therapeutics investors

5 investors are on record for Remedy Plan Therapeutics, including Alexandria Venture Investments, Schooner Capital, 20/20 HealthCare Partners and Maryland Tech Council.

About Remedy Plan Therapeutics

Developer of medical drugs designed to halt tumor growth and prevent cancer. The company's drugs disrupt cancer stem cells by transforming the field of NAMPT inhibition with an approach that allows for hyperbolic inhibition, enabling the healthcare industry to address solid tumors, hematologic malignancies, obesity, and autoimmune disorders.

Sector
Healthcare
HQ
Gaithersburg, MD, United States
Founded
2012
Employees
15
Ownership
Privately Held (backing)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.